# Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy

> **NCT02329639** · — · COMPLETED · sponsor: **University of Pisa** · enrollment: 307 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **GENETIC:** genetic interaction analysis

## Key facts

- **NCT ID:** NCT02329639
- **Lead sponsor:** University of Pisa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2025-10
- **Final completion:** 2026-04
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02329639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02329639, "Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT02329639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*